Perspective TherapeuticsCATX
13F holders, Q1 2025 (March 31)2holders +1
1new positions
0sold out
$2.13avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Perspective Therapeutics Inc. (CATX) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Vestor Capital, LLC ($2.1M) and Portland Investment Counsel Inc. ($405K).
- Company
- Perspective Therapeutics Inc.
- CUSIP
- 46489V104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2.1M |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,014,720 shares bought, net +1,014,720 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Vestor Capital, LLC | 0.17% | New | 974,720 | $2.1M |
| Portland Investment Counsel Inc. | 0.12% | Add +26.7% | 190,000 | $405K |
"% of holder's portfolio" is CATX's weight in each manager's 13F, not the share of Perspective Therapeutics Inc. the manager owns.